Type 2 Diabetes Treatment - Part 7 - GLP-1 Agonists and DPP-4 Inhibitors - a podcast by Gil Porat, M.D., FACP, CPT

Glucagon-Like Peptide 1 (GLP-1) mimetics are also referred to as the GLP-1 receptor agonists. While this talk mostly focuses on GLP-1 mechanisms and actions, the hope is you will also better understand The Dipeptidyl Peptidase-4 (DPP-4) inhibitors 

The current GLP-1 Agonists include Exenatide (Byetta), Liraglutide (Victoza), Dulaglutide (Trulicity), Abiglutide (Tanzeum), Lixisenatide (Adlyxin), Semaglutide (Ozempic).

The current DPP-4 Inhibitors include Alogliptin (Nesina), Linagliptin (Tradjenta), Saxagliptin (Onglyza), Sitagliptin (Januvia). 

Further episodes of Hospital and Internal Medicine Podcast

Further podcasts by Gil Porat, M.D., FACP, CPT

Website of Gil Porat, M.D., FACP, CPT